Page last updated: 2024-10-29

iofetamine and Angelman Syndrome

iofetamine has been researched along with Angelman Syndrome in 1 studies

Iofetamine: An amphetamine analog that is rapidly taken up by the lungs and from there redistributed primarily to the brain and liver. It is used in brain radionuclide scanning with I-123.

Angelman Syndrome: A syndrome characterized by multiple abnormalities, MENTAL RETARDATION, and movement disorders. Present usually are skull and other abnormalities, frequent infantile spasms (SPASMS, INFANTILE); easily provoked and prolonged paroxysms of laughter (hence happy); jerky puppetlike movements (hence puppet); continuous tongue protrusion; motor retardation; ATAXIA; MUSCLE HYPOTONIA; and a peculiar facies. It is associated with maternal deletions of chromosome 15q11-13 and other genetic abnormalities. (From Am J Med Genet 1998 Dec 4;80(4):385-90; Hum Mol Genet 1999 Jan;8(1):129-35)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Odano, I1
Anezaki, T1
Ohkubo, M1
Yonekura, Y1
Onishi, Y1
Inuzuka, T1
Takahashi, M1
Tsuji, S1

Other Studies

1 other study available for iofetamine and Angelman Syndrome

ArticleYear
Decrease in benzodiazepine receptor binding in a patient with Angelman syndrome detected by iodine-123 iomazenil and single-photon emission tomography.
    European journal of nuclear medicine, 1996, Volume: 23, Issue:5

    Topics: Adult; Amphetamines; Angelman Syndrome; Brain; Cerebrovascular Circulation; Female; Flumazenil; Huma

1996